ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Another emerging arbovirus, another emerging vaccine: Targeting Zika virus [Editorial] (2016)
Palacios, Ricardo; Poland, Gregory A.; Kalil, Jorge
Source: Vaccine. Unidade: FM
Subjects: ZIKA VÍRUS, VETORES, VÍRUS DA DENGUE, TRANSMISSÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALACIOS, Ricardo e POLAND, Gregory A. e KALIL, Jorge. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus [Editorial]. Vaccine. Kidlington: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.vaccine.2016.03.059. Acesso em: 11 nov. 2024. , 2016
APA
Palacios, R., Poland, G. A., & Kalil, J. (2016). Another emerging arbovirus, another emerging vaccine: Targeting Zika virus [Editorial]. Vaccine. Kidlington: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.vaccine.2016.03.059
NLM
Palacios R, Poland GA, Kalil J. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus [Editorial] [Internet]. Vaccine. 2016 ; 34( 20): 2291-2293.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2016.03.059
Vancouver
Palacios R, Poland GA, Kalil J. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus [Editorial] [Internet]. Vaccine. 2016 ; 34( 20): 2291-2293.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2016.03.059
Artigo de periodico
Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes (2014)
De Amicis, Karine M.; Barros, Samar Freschi de; Alencar, Raquel E.; Postól, Edilberto; Martins, Carlo de Oliveira; Arcuri, Helen Andrade; Goulart, Cibelly; Kalil, Jorge; Guilherme, Luiza
Source: Vaccine. Unidade: FM
Subjects: IMUNOLOGIA, VACINAS, FEBRE REUMÁTICA, STREPTOCOCCUS PYOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE AMICIS, Karine M. et al. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes. Vaccine, v. 32, n. 32, p. 4104-4110, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2013.08.043. Acesso em: 11 nov. 2024.
APA
De Amicis, K. M., Barros, S. F. de, Alencar, R. E., Postól, E., Martins, C. de O., Arcuri, H. A., et al. (2014). Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes. Vaccine, 32( 32), 4104-4110. doi:10.1016/j.vaccine.2013.08.043
NLM
De Amicis KM, Barros SF de, Alencar RE, Postól E, Martins C de O, Arcuri HA, Goulart C, Kalil J, Guilherme L. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes [Internet]. Vaccine. 2014 ; 32( 32): 4104-4110.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2013.08.043
Vancouver
De Amicis KM, Barros SF de, Alencar RE, Postól E, Martins C de O, Arcuri HA, Goulart C, Kalil J, Guilherme L. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes [Internet]. Vaccine. 2014 ; 32( 32): 4104-4110.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2013.08.043
Artigo de periodico
Identification of novel immunoregulatory molecules in human thymic regulatory 'CD4 POT. +''CD25 POT. +' T cells by phage display (2011)
Porto, Georgia; Giordano, Ricardo José ; Marti, Luciana Cavalheiro; Stolf, Beatriz Simonsen ; Pasqualini, Renata; Arap, Wadih; Kalil, Jorge; Coelho, Verônica
Source: PLOS ONE. Unidades: IQ, FM, ICB
Subjects: VITAMINA D, BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PORTO, Georgia et al. Identification of novel immunoregulatory molecules in human thymic regulatory 'CD4 POT. +''CD25 POT. +' T cells by phage display. PLOS ONE, v. 6, n. 8, p. 1-9 art. e21702, 2011Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0021702. Acesso em: 11 nov. 2024.
APA
Porto, G., Giordano, R. J., Marti, L. C., Stolf, B. S., Pasqualini, R., Arap, W., et al. (2011). Identification of novel immunoregulatory molecules in human thymic regulatory 'CD4 POT. +''CD25 POT. +' T cells by phage display. PLOS ONE, 6( 8), 1-9 art. e21702. doi:10.1371/journal.pone.0021702
NLM
Porto G, Giordano RJ, Marti LC, Stolf BS, Pasqualini R, Arap W, Kalil J, Coelho V. Identification of novel immunoregulatory molecules in human thymic regulatory 'CD4 POT. +''CD25 POT. +' T cells by phage display [Internet]. PLOS ONE. 2011 ; 6( 8): 1-9 art. e21702.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1371/journal.pone.0021702
Vancouver
Porto G, Giordano RJ, Marti LC, Stolf BS, Pasqualini R, Arap W, Kalil J, Coelho V. Identification of novel immunoregulatory molecules in human thymic regulatory 'CD4 POT. +''CD25 POT. +' T cells by phage display [Internet]. PLOS ONE. 2011 ; 6( 8): 1-9 art. e21702.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1371/journal.pone.0021702
Artigo de periodico
HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate (2011)
Guerino, Milton T.; Postol, Edilberto; Demarchi, Lea M. F.; Martins, Carlo O.; Mundel, Luiz R.; Kalil, Jorge; Guilherme , Luiza
Source: Vaccine. Unidade: FM
Subjects: CAMUNDONGOS, INFECÇÕES ESTREPTOCÓCICAS, HISTOPATOLOGIA ANIMAL, VACINAS VIRAIS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERINO, Milton T. et al. HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate. Vaccine, v. 29, n. 46, p. 8250-8256, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2011.08.113. Acesso em: 11 nov. 2024.
APA
Guerino, M. T., Postol, E., Demarchi, L. M. F., Martins, C. O., Mundel, L. R., Kalil, J., & Guilherme , L. (2011). HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate. Vaccine, 29( 46), 8250-8256. doi:10.1016/j.vaccine.2011.08.113
NLM
Guerino MT, Postol E, Demarchi LMF, Martins CO, Mundel LR, Kalil J, Guilherme L. HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate [Internet]. Vaccine. 2011 ; 29( 46): 8250-8256.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2011.08.113
Vancouver
Guerino MT, Postol E, Demarchi LMF, Martins CO, Mundel LR, Kalil J, Guilherme L. HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate [Internet]. Vaccine. 2011 ; 29( 46): 8250-8256.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2011.08.113
Artigo de periodico
The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil (2010)
Ramasawmy, Rajendranath; Menezes, Eliane; Magalhães, Andrea; Oliveira, Joyce; Castellucci, Léa; Almeida, Roque; Rosa, Maria Elisa A.; Guimães, Luiz Henrique; Lessa, Marcus; Noronha, Elza; Wilson, Mary E.; Jamieson, Sarra E.; Kalil, Jorge; Blackwell, Jenefer M.; Carvalho, Edgar M.; Jesus, Amélia Ribeiro de
Source: Infection, Genetics and Evolution. Unidade: FM
Subjects: POLIMORFISMO, INFLAMAÇÃO, GENÓTIPOS, LEISHMANIOSE CUTÂNEA (GENÉTICA), BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMASAWMY, Rajendranath et al. The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infection, Genetics and Evolution, v. 10, n. 5, p. 607-613, 2010Tradução . . Disponível em: http://www.sciencedirect.com/science/article/pii/S1567134810001048. Acesso em: 11 nov. 2024.
APA
Ramasawmy, R., Menezes, E., Magalhães, A., Oliveira, J., Castellucci, L., Almeida, R., et al. (2010). The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infection, Genetics and Evolution, 10( 5), 607-613. doi:10.1016/j.meegid.2010.04.006
NLM
Ramasawmy R, Menezes E, Magalhães A, Oliveira J, Castellucci L, Almeida R, Rosa MEA, Guimães LH, Lessa M, Noronha E, Wilson ME, Jamieson SE, Kalil J, Blackwell JM, Carvalho EM, Jesus AR de. The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil [Internet]. Infection, Genetics and Evolution. 2010 ; 10( 5): 607-613.[citado 2024 nov. 11 ] Available from: http://www.sciencedirect.com/science/article/pii/S1567134810001048
Vancouver
Ramasawmy R, Menezes E, Magalhães A, Oliveira J, Castellucci L, Almeida R, Rosa MEA, Guimães LH, Lessa M, Noronha E, Wilson ME, Jamieson SE, Kalil J, Blackwell JM, Carvalho EM, Jesus AR de. The −2518 bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil [Internet]. Infection, Genetics and Evolution. 2010 ; 10( 5): 607-613.[citado 2024 nov. 11 ] Available from: http://www.sciencedirect.com/science/article/pii/S1567134810001048

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em